These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23095431)

  • 21. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D; Narendran P; Qvist M; Niemeyer M; Nadeau DA
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1259-69. PubMed ID: 21905942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2008 resource guide. Insulin delivery. Syringes..pumps..jet injectors..pens..infusers...they all do the same thing: deliver insulin through the outermost layer of skin and into fatty tissue so it can be used by the body.
    Diabetes Forecast; 2008 Jan; 61(1):RG17-29. PubMed ID: 18290289
    [No Abstract]   [Full Text] [Related]  

  • 23. [Insulin pens for treatment of diabetes].
    Bärtsch U; Comtesse Ch; Wetekam B
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FlexPen for the delivery of insulin: accuracy, injection force and patient preference.
    Pfützner A
    Expert Rev Med Devices; 2009 Mar; 6(2):115-23. PubMed ID: 19298158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The importance of patient compliance with insulin pens: how can a new user-friendly pen help?
    Pafili K; Papanas N
    Expert Opin Drug Deliv; 2014 May; 11(5):629-32. PubMed ID: 24661150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe.
    Molife C; Lee LJ; Shi L; Sawhney M; Lenox SM
    Diabetes Technol Ther; 2009 Aug; 11(8):529-38. PubMed ID: 19698067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prescription of insulin pen devices versus syringes for older people with diabetes.
    Shaghouli AA; Shah BR
    Diabetes Technol Ther; 2009 Jul; 11(7):439-42. PubMed ID: 19580357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which insulin, regimen and device in type 2 diabetes?
    Drug Ther Bull; 2010 Dec; 48(12):134-8. PubMed ID: 21123289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin pens.
    Berg EG
    Diabetes Forecast; 2014 Jan; 67(1):68-9. PubMed ID: 25868299
    [No Abstract]   [Full Text] [Related]  

  • 34. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe.
    Stockl K; Ory C; Vanderplas A; Nicklasson L; Lyness W; Cobden D; Chang E
    Curr Med Res Opin; 2007 Jan; 23(1):133-46. PubMed ID: 17257475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical aspects of insulin pen devices.
    Pearson TL
    J Diabetes Sci Technol; 2010 May; 4(3):522-31. PubMed ID: 20513316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Though costly, insulin pens facilitate better adherence.
    Reinke T
    Manag Care; 2013 Jun; 22(6):20-1. PubMed ID: 23837286
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of utilization, cost, adherence, and hypoglycemia in patients with type 2 diabetes initiating rapid-acting insulin analog with prefilled pen versus vial/syringe.
    Lee LJ; Li Q; Reynolds MW; Pawaskar MD; Corrigan SM
    J Med Econ; 2011; 14(1):75-86. PubMed ID: 21231863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe.
    Graff MR; McClanahan MA
    Clin Ther; 1998; 20(3):486-96. PubMed ID: 9663364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
    Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
    Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Novolet--a pen-device for insulin self-injection by disabled diabetics].
    Kisch ES; Cohen Y; Arbeli S
    Harefuah; 1996 May; 130(9):604-5, 655. PubMed ID: 8794639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.